PRME: FDA Grants Designation
Prime Medicine says FDA grants regenerative medicine advanced therapy designation to PM359 for treatment of p47phox-deficient CGD
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Prime Medicine says FDA grants regenerative medicine advanced therapy designation to PM359 for treatment of p47phox-deficient CGD